Polyrizon Ltd. (US:PLRZ) faced a Nasdaq delisting concern primarily due to the specific terms of the Series A warrants issued in its private placement on March 31, 2025. Nasdaq's Listing Qualifications Department determined that the issuance of these securities, particularly the Series A warrants exercisable on an "alternate cashless basis," raised "public interest concerns" under Listing Rule 5101.1
The key terms that caused the concern were:
- Alternate Cashless Exercise Option: The Series A Warrants allowed for an alternative cashless exercise. This provision was identified by Nasdaq as a significant factor leading to potential substantial dilution for existing shareholders.1 One filing describes this option as allowing the warrant holder to receive an aggregate number of shares equal to the number of Ordinary Shares issuable upon a cash exercise, multiplied by 3.0.2
- Adjustments and Anti-Dilution Protection: The number of securities issuable under the Series A Warrants and their exercise price were subject to certain adjustments and anti-dilution protection, which depended on the then-current share price, subject to a floor price.2 This characteristic meant the warrants did not meet US GAAP criteria for equity classification and were instead recognized as a liability.2
Nasdaq's concern stemmed from the potential for "substantial dilution" to shareholders resulting from these warrant terms.3 Following a hearing, Polyrizon retained its Nasdaq listing, committing to avoid such complex and dilutive financing instruments in the future and implementing enhanced internal controls.1 By July 15, 2025, all warrants from the private placement had been exercised, which the company stated simplified its capital structure.1
